Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.505
-0.122 (-19.44%)
At close: Nov 4, 2024, 4:00 PM
0.510
+0.005 (1.01%)
After-hours: Nov 4, 2024, 7:59 PM EST

Cyclacel Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
138393812
Upgrade
Market Cap Growth
-67.91%-67.46%-78.45%2.15%229.64%52.41%
Upgrade
Enterprise Value
-5-3-15-116-0
Upgrade
Last Close Price
0.632.6710.0058.35117.15201.00
Upgrade
PE Ratio
--0.10-0.35-1.86-2.28-1.36
Upgrade
PS Ratio
14.156.48----
Upgrade
PB Ratio
1.134.480.521.031.140.99
Upgrade
P/FCF Ratio
-0.21-0.17-0.40-2.09-4.73-1.22
Upgrade
P/OCF Ratio
-0.21-0.17-0.40-2.09-4.79-1.22
Upgrade
EV/Sales Ratio
-5.08-7.55----
Upgrade
EV/EBITDA Ratio
0.020.120.550.06-1.500.03
Upgrade
EV/EBIT Ratio
0.020.120.550.06-1.500.03
Upgrade
EV/FCF Ratio
0.040.200.730.07-1.980.03
Upgrade
Debt / Equity Ratio
0.010.060.010.000.030.10
Upgrade
Debt / FCF Ratio
0.000.00-0.010.00-0.13-0.13
Upgrade
Asset Turnover
0.010.02----
Upgrade
Quick Ratio
0.970.773.067.4413.975.46
Upgrade
Current Ratio
1.070.913.257.5614.275.79
Upgrade
Return on Equity (ROE)
-570.69%-272.63%-79.05%-52.03%-37.57%-58.07%
Upgrade
Return on Assets (ROA)
-102.53%-86.33%-48.56%-35.01%-25.51%-34.45%
Upgrade
Return on Capital (ROIC)
-406.94%-190.64%-64.29%-38.85%-28.16%-42.98%
Upgrade
Earnings Yield
-1422.56%-828.75%-253.45%-47.57%-22.23%-67.95%
Upgrade
FCF Yield
-930.25%-592.23%-249.10%-47.85%-21.14%-82.06%
Upgrade
Buyback Yield / Dilution
-116.69%-13.38%-26.10%-145.67%-345.23%-34.95%
Upgrade
Total Shareholder Return
-116.69%-13.38%-26.10%-145.67%-345.23%-34.95%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.